Publicacions en què col·labora amb Miguel Blanco Álvarez (12)

2015

  1. Study of Protein Expresion in Peri-Infarct Tissue after Cerebral Ischemia

    Scientific Reports, Vol. 5

2014

  1. Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia

    Cell Death and Disease, Vol. 5, Núm. 1

  2. In vivo theranostics at the peri-infarct region in cerebral ischemia

    Theranostics, Vol. 4, Núm. 1, pp. 90-105

  3. Quick adjustment of imaging tracer payload, for in vivo applications of theranostic nanostructures in the brain

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 10, Núm. 4, pp. 851-858

2013

  1. Interleukin-10 facilitates the selection of patients for systemic thrombolysis

    BMC Neurology, Vol. 13

2012

  1. Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

    PLoS ONE, Vol. 7, Núm. 8

  2. Influence of temperature on ischemic brain: Basic and clinical principles

    Neurochemistry International

  3. Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke

    Neuropharmacology, Vol. 63, Núm. 8, pp. 1279-1285

2011

  1. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1387-1393

  2. Los niveles de expresión de los receptores toll-like 2 y 4 en neutrófilos se asocian con el pronóstico de los pacientes con ictus isquémico

    Revista de Neurologia, Vol. 52, Núm. 1, pp. 12-19

  3. Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1424-1431

  4. Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke

    Clinical Immunology, Vol. 139, Núm. 2, pp. 193-198